Stahl, Stephen M.

Practical guide for prescribing MAOIs: debunking myths and removing barriers

Grady, M. M., & Stahl, S. M. (2012) · CNS Spectrums

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 51

Inhibition of REM sleep by ipsapirone, A 5HT1A agonist, in normal volunteers

Gillin, J. C., Jernajczyk, W., Valladares-Neto, D. D. C., Golshan, S., Lardon, M., & Stahl, S. M. (1994) · Psychopharmacology

Sleep and Wakefulness ResearchSleep and related disorders

Cited by 50

Enhancing Outcomes from Major Depression: Using Antidepressant Combination Therapies with Multifunctional Pharmacologic Mechanisms from the Initiation of Treatment

Stahl, S. M. (2010) · CNS Spectrums

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 40

Pharmacological Comparative Characterization of REL-1017 (Esmethadone-HCl) and Other NMDAR Channel Blockers in Human Heterodimeric N-Methyl-D-Aspartate Receptors

Bettini, E., Stahl, S. M., De Martin, S., Mattarei, A., Sgrignani, J., Carignani, C., Nola, S., Locatelli, P., Pappagallo, M., Inturrisi, C. E., et al. (2022) · Pharmaceuticals

Neuroscience and Neuropharmacology ResearchTreatment of Major Depression

Cited by 31

REL-1017 (Esmethadone) Increases Circulating BDNF Levels in Healthy Subjects of a Phase 1 Clinical Study

De Martin, S., Gabbia, D., Folli, F., Bifari, F., Fiorina, P., Ferri, N., Stahl, S., Inturrisi, C. E., Pappagallo, M., Traversa, S., et al. (2021) · Frontiers in Pharmacology

Treatment of Major DepressionNerve injury and regeneration

Cited by 28

Demystifying the Antidepressant Mechanism of Action of Stinels, a Novel Class of Neuroplastogens: Positive Allosteric Modulators of the NMDA Receptor

Donello, J. E., McIntyre, R. S., Pickel, D. B., & Stahl, S. M. (2025) · Pharmaceuticals

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 15

Comparing the pharmacology and pharmacokinetics of antipsychotics: Choosing an antipsychotic and dosing a long-acting injectable

Stahl, S. M., & Djokic, G. (2023) · European Neuropsychopharmacology

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 12

Norepinephrine and Dopamine Regulate Signals and Noise in the Prefrontal Cortex: (Brainstorms)

Stahl, S. M. (2009) · The Journal of Clinical Psychiatry

Neurotransmitter Receptor Influence on BehaviorNeural and Behavioral Psychology Studies

Cited by 11

Polypharmacy- Purpose, Benefits and Limitations

Grover, D., Tom, M., Maguire, G., & Stahl, S. (2022) · Current Medicinal Chemistry

Pharmaceutical Practices and Patient OutcomesChronic Disease Management Strategies

Cited by 7

Medications for psychosis in people with schizophrenia: what happens if you take them and what happens if you don’t?

Faizi, A., & Stahl, S. M. (2025) · CNS Spectrums

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 0